Mesa Laboratories Inc
MLAB· Nasdaq
MLABMesa Laboratories Inc
Filed Jun 28, 2024 · 10-K · 89 days after period end · 0001437749-24-021606
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $58.90M | $55.59M | $58.88M | $37.96M |
| Net Income | -$254.58M | $611.00K | -$1.78M | $3.92M |
| EPS Diluted | — | — |
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
| — |
| $0.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2024 · filed Jun 28, 2024 · 89 d after period end
